Cargando…
Altered Insulin Signaling in Alzheimer’s Disease Brain – Special Emphasis on PI3K-Akt Pathway
Alzheimer’s disease (AD) and type 2 diabetes (T2D) are both diseases with increasing prevalence in aging populations. T2D, characterized by insulin resistance and defective insulin signaling, is a common co-morbidity and a risk factor for AD, increasing the risk approximately two to fourfold. Insuli...
Autores principales: | Gabbouj, Sami, Ryhänen, Simo, Marttinen, Mikael, Wittrahm, Rebekka, Takalo, Mari, Kemppainen, Susanna, Martiskainen, Henna, Tanila, Heikki, Haapasalo, Annakaisa, Hiltunen, Mikko, Natunen, Teemu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591470/ https://www.ncbi.nlm.nih.gov/pubmed/31275108 http://dx.doi.org/10.3389/fnins.2019.00629 |
Ejemplares similares
-
Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer’s Disease
por: Marttinen, Mikael, et al.
Publicado: (2018) -
MECP2 Increases the Pro-Inflammatory Response of Microglial Cells and Phosphorylation at Serine 423 Regulates Neuronal Gene Expression upon Neuroinflammation
por: Wittrahm, Rebekka, et al.
Publicado: (2021) -
Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques
por: Natunen, Teemu, et al.
Publicado: (2020) -
The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
por: Takalo, Mari, et al.
Publicado: (2020) -
Decreased plasma C‐reactive protein levels in APOE ε4 allele carriers
por: Martiskainen, Henna, et al.
Publicado: (2018)